Clinical Trials for Mercator MedSystems

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Mercator MedSystems

Clinical Trials (3)

NCT04433572
Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
PHASE3Recruiting
250 participants
Started: Jul 30, 2025 · Completed: Aug 1, 2032
2 conditions1 sponsor2 locations
NCT04858776
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT
PHASE2Recruiting
60 participants
Started: Aug 8, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor15 locations
NCT04862468
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
PHASE2Recruiting
80 participants
Started: Oct 29, 2021 · Completed: Feb 1, 2028
2 conditions2 sponsors17 locations